Evaluation of cerebrospinal fluid neurofilament light chain levels in multiple sclerosis and non-demyelinating diseases of the central nervous system: clinical and biochemical perspective. Biomol Biomed [Internet]. 2022 Sep. 16 [cited 2024 Apr. 29];22(5):699-706. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/7326